Riveridge Rehabilitation & Healthcare Center | |
1333 Wells St, Niles, Michigan 49120 | |
(269) 684-1111 | |
Name | Riveridge Rehabilitation & Healthcare Center |
---|---|
Location | 1333 Wells St, Niles, Michigan |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 84 |
Occupancy Rate | 76.67% |
Medicare ID (CCN) | 235598 |
Legal Business Name | Riveridge Investments & Associates Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1164413282 |
Organization Name | RIVERIDGE INVESTMENTS & ASSOCIATES, LLC |
Doing Business As | RIVERIDGE MANOR |
Address | 1333 Wells St, Niles, MI 49120 |
Phone Number | 269-684-1111 |
News Archive
Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.
You don't think you're hungry, then a friend mentions how hungry he is or you smell some freshly baked pizza and whoaaa, you suddenly feel really hungry. Or, you've had surgery and need a bit of morphine for pain. As soon as you hit that button you feel relief even though the medicine hasn't even hit your bloodstream.
The Department of Justice announced today that Raynor Country Day School, in Long Island, N.Y., has entered into a settlement agreement with the United States to resolve two complaints filed by parents of children with diabetes who were turned down for enrollment in the school's day camp last summer.
Today launches the sixth World Conference on Breast Cancer in Hamilton, Canada. The Conference is the only one of its kind to bring together breast cancer survivors, advocates, health-care professionals and researchers from developing and developed countries.
Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.
› Verified 4 days ago
NPI Number | 1659996973 |
Organization Name | NILES MI OPCO LLC |
Address | 1333 Wells St, Niles, MI 49120 |
Phone Number | 269-684-1111 |
News Archive
Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.
You don't think you're hungry, then a friend mentions how hungry he is or you smell some freshly baked pizza and whoaaa, you suddenly feel really hungry. Or, you've had surgery and need a bit of morphine for pain. As soon as you hit that button you feel relief even though the medicine hasn't even hit your bloodstream.
The Department of Justice announced today that Raynor Country Day School, in Long Island, N.Y., has entered into a settlement agreement with the United States to resolve two complaints filed by parents of children with diabetes who were turned down for enrollment in the school's day camp last summer.
Today launches the sixth World Conference on Breast Cancer in Hamilton, Canada. The Conference is the only one of its kind to bring together breast cancer survivors, advocates, health-care professionals and researchers from developing and developed countries.
Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.
You don't think you're hungry, then a friend mentions how hungry he is or you smell some freshly baked pizza and whoaaa, you suddenly feel really hungry. Or, you've had surgery and need a bit of morphine for pain. As soon as you hit that button you feel relief even though the medicine hasn't even hit your bloodstream.
The Department of Justice announced today that Raynor Country Day School, in Long Island, N.Y., has entered into a settlement agreement with the United States to resolve two complaints filed by parents of children with diabetes who were turned down for enrollment in the school's day camp last summer.
Today launches the sixth World Conference on Breast Cancer in Hamilton, Canada. The Conference is the only one of its kind to bring together breast cancer survivors, advocates, health-care professionals and researchers from developing and developed countries.
Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $8294 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 30.46 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.65 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 33.33 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.39 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.99 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.45 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.35 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.99 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 28.28 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 53.62 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 4.5 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 54.94 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.34 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.26 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 82.08 | 95.98 |
Percentage of short-stay residents who made improvements in function | 30.81 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.23 | 82.93 |
News Archive
Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.
You don't think you're hungry, then a friend mentions how hungry he is or you smell some freshly baked pizza and whoaaa, you suddenly feel really hungry. Or, you've had surgery and need a bit of morphine for pain. As soon as you hit that button you feel relief even though the medicine hasn't even hit your bloodstream.
The Department of Justice announced today that Raynor Country Day School, in Long Island, N.Y., has entered into a settlement agreement with the United States to resolve two complaints filed by parents of children with diabetes who were turned down for enrollment in the school's day camp last summer.
Today launches the sixth World Conference on Breast Cancer in Hamilton, Canada. The Conference is the only one of its kind to bring together breast cancer survivors, advocates, health-care professionals and researchers from developing and developed countries.
Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.
› Verified 4 days ago
Riveridge Rehabilitation & Healthcare Center Location: 1333 Wells St, Niles, Michigan 49120 Phone: (269) 684-1111 |